Epidemiological studies demonstrated that a high level of leptin in serum is positively correlated with the risk of melanoma, while in vivo, injection of leptin into melanoma-bearing mice led to the increase in weight and size of the tumor [128,133]. This evidence concerns the gene LEP and neoplasm.